Clinical and diagnostic aspects of dry eye syndrome and peripheral retina changes

Written by Kravchenko A.V., Shilova O.G.

  UDK: 617.711-004.1/.73-07-085 DOI: 10.17238/PmJ1609-1175.2016.3.29–32 | Pages: 29–32 | Full text PDF | Open PDF 


Objective. Research objective is to correlate the manifestation degree of dry eye syndrome (DES) and the severity of changes in peripheral retina parts during ophthalmological therapy. Methods. The research includes 94 patients with DES of mild and medium severity. Patients got lacrimal substitute therapy and local anti-inflammatory therapy. We diagnosed the front eye surface: the assessment of personal amelioration according to OSDI questionnaire, detecting of tear breakup time, sample colored with fluorescein, Schirmer’s test, ophthalmoscopic examination of the peripheral retina parts. Follow-up time is 6 months. Results. It was built the logit-regressive models, showing the possibility of degeneration occurrencein peripheral retina parts with the factors changes, characterizing the state of the front eye surface and lacrimal apparatus. Conclusions. The possibility of occurrence of significant and inconvertible changes in peripheral retina parts maintained while correlating with the lacrimal factors for a month after the treatment started. The therapy by the 3rd months led to the break of connectivity of these factors.

Links to authors:

A.V. Kravchenko, O.G. Shilova
Siberian State Medical University (4 Lenina Ave. Tomsk 634028 Russian Federation)

1. Brzheskiy V.V. ‹Dry eye› syndrome // Ophthalmology: national guideline / edited by S.E. Avetisov [et al.]. М.: GEOTAR-Media, 2008. P. 388–399.
2. Brzheskiy V.V., Somov E.E. Corneoconjunctival xerosis. StP.: Levsha, 2003. 120 p.
3. Gagarina T.A. Modern methods of treatment of peripheral uveitis // Issues of ophthalmic endocrinology and vascular malformation: materials of regional scientific conference of ophthalmologists abd endocrinologists. Krasnoyarsk, 1999. P. 90–92.
4. Kudryashova Yu.I. Immune-mediated form of ‹dry eye› syndrome: clinical features, pathogenesis, the combinated treatment: thesis, MD. Chelyabinsk, 2007. 245 p.
5. Maychuk Yu.F., Mironkova E.A. The choice of therapy in the syndrome of ‹dry eye› in violation of the lipid layer stability of the tear film at meibomian gland dysfunction // Refractive Surgery and Ophthalmology. 2007. No. 3. P. 57–60.
6. Polunin G.S., Polunina E.G. ‹Dry Eye› // For those who treat: supplement to the journal ‹Health›. 2007. No. 3. P. 4–33.
7. Polunina E.G. ‹Dry eye› syndrome // Ophthalmology. 2004. No. 2. P. 53–61.
8. Lozato P.A., Pisella P.J., Baudouin C. Phase lipidique du film lacrymal: physiologie et pathologie // J. Fr. Ophtalmol. 2001. Vol. 24. P. 643–658.
9. Gayton J.L. Etiology, prevalence, and treatment of dry eye disease // Clin. Ophthalmol. 2009. Vol. 3. P. 405–412.
10. Garreis P., Gottschalt M., Schlorf T. [at al.]. The antimicrobial peptide psoriasin at the ocular surface // 9th congress of the international society of dacryology and dry eye. 2008. P. 41–42.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.